Phenoxymethyl piperidine derivatives for the treatment of neurop

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514331, 546232, 546236, 546240, A61K 31452, C07D21118

Patent

active

061109371

ABSTRACT:
Compounds selected from the group of compounds represented by Formula I: ##STR1## as an individual isomer or as a racemic or non-racemic mixture of isomers, and their pharmaceutically acceptable salts and N-oxides thereof; are sodium channel blockers, and thus exhibit useful pharmacological properties, including utility for the treatment of neuropathic pain conditions.

REFERENCES:
patent: 3634437 (1972-01-01), Todd
patent: 3709892 (1973-01-01), Leeming et al.
patent: 4508724 (1985-04-01), Taylor, Jr. et al.
patent: 4822778 (1989-04-01), Aberg et al.
patent: 4877799 (1989-10-01), Drejer et al.
patent: 4985446 (1991-01-01), Drejer et al.
patent: 5019582 (1991-05-01), Drejer et al.
patent: 5158961 (1992-10-01), Jakobsen et al.
patent: 5210086 (1993-05-01), George et al.
patent: 5227379 (1993-07-01), Jakobsen et al.
Arya et al., Indian J. Chem (1977), vol. 15B, pp. 1125-1128, "Synthesis & CNS Depressant Activity of Some Pyridyl & Piperidyl Ethers".
Balsamo et al., J. Med. Chem. (1987), vol. 30, pp. 222-225, "3-[(2-Ethoxyphenoxy)methyl]piperidine Derivatives. Synthesis and Antidepressant Activity".
Catterall, Trends in Pharmacological Science, vol. 8, No. 2, pp. 57-65 (1987), "Common Modes of Drug Action on Na+ Channels: Local Anesthetics, Antiarrhythmics and Anticonvulsants".
Ragsdale et al, Molecular Pharmacology, vol. 40, No. 5, pp. 756-765 (1991), "Frequency and Voltage-Dependent Inhibition of Type IIA Na+ Channels, Expressed in a Mammalian Cell Line, by Local Anesthetic, Antiarrhythmic, and Anticonvulsant Drugs".
Tolatsky et al, Cardiovascular Drug Review, vol. 7, No. 3, pp. 199-209 (1989), "K+ Channel Blockers and Activators in Cardiac Arrhythmias".
Hondeghem et al, Annual Review. Pharmacol. Toxicol, vol. 24, pp. 387-423 (1984), Antiarrhythmic Agents: The Modulated Receptor Mechanism of Action of Sodium and Calcium Channel-Blocking Drugs.
Roufos et al, Journal of Medical Chemistry, vol. 39, No. 7, pp. 1514-1520 (1996), "A Structure-Activity Relationship Study of Novel Phenylacetamides Which are Sodium Channel Blockers".
Journal of Medical Chemistry, vol. 37, No. 2, pp. 268-274, (1994), "Synthesis and Pharmacological Evaluation of Phenylacetamides as Sodium-Channel Blockers".

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Phenoxymethyl piperidine derivatives for the treatment of neurop does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Phenoxymethyl piperidine derivatives for the treatment of neurop, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phenoxymethyl piperidine derivatives for the treatment of neurop will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1250255

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.